Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global blood plasma derivatives market reached a value of US$ 40.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 59.8 Billion by 2027, exhibiting a CAGR of 6.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.

Breakup by Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others
     

Breakup by Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others
     

Breakup by End User:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Blood Plasma Derivatives Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Albumin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Factor VIII
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Factor IX
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Immunoglobulin
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Hyperimmune Globulin
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Application
    7.1    Hemophilia
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Hypogammaglobulinemia
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunodeficiency Diseases
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Von Willebrand's Disease
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Baxter International Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Bayer AG
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    CSL Limited
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Fusion Health Care Pvt. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Grifols S.A.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Kedrion S.p.A.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    LFB S.A.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Octapharma AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 SWOT Analysis
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Takeda Pharmaceutical Company Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2021
Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2021
Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2021
Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2021
Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
Table 7: Global: Blood Plasma Derivatives Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global blood plasma derivatives market was valued at US$ 40.5 Billion in 2021.

We expect the global blood plasma derivatives market to exhibit a CAGR of 6.40% during 2022-2027.

Extensive R&D activities for understanding the potency of blood plasma products in several therapeutic treatments, including immunology, oncology, pulmonology, rheumatology, neurology, etc., are primarily driving the global blood plasma derivatives market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of blood plasma derivatives to treat the patients suffering from the coronavirus infection, thereby positively influencing the market growth.

Based on the type, the global blood plasma derivatives market has been segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. Among these, immunoglobulin currently holds the majority of the total market share.

Based on the end-user, the global blood plasma derivatives market can be divided into hospitals, clinics, and others. Currently, hospitals exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global blood plasma derivatives market include Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links